Any clinical benefit from the use of oncofoetal markers in the management of chemotherapy for patients with metastatic colorectal carcinomas?
Trillet-Lenoir V, Chapuis F, Touzet S, Barbier JY, Freyer G, Gaudin JL, Lombard-Bohas C, Valette PJ, Lledo G, Gouttebel MC, Boyer JD, Chassignol L, Hamon H, Claudel-Bonvoisin S, Leprince E, Amoyal P, Glehen O, Darnand P, Heilmann MO, Bleuse JP.
Trillet-Lenoir V, et al. Among authors: glehen o.
Clin Oncol (R Coll Radiol). 2004 May;16(3):196-203. doi: 10.1016/j.clon.2003.11.005.
Clin Oncol (R Coll Radiol). 2004.
PMID: 15191007
Clinical Trial.